Fact of the Week: If Drug Price Controls Were Lifted Throughout the OECD, the Number of new Treatments Available Would Increase 9 to 12 Percent by 2030

June 18, 2018

If other countries paid their fair share for novel medicines, we’d all have more of them. New research from Precision Health Economics finds that if government price controls in non-U.S. OECD countries were lifted, the number of new treatments available would increase by 9 to 12 percent by 2030 (equivalent to 8 to 13 new drugs in that year), potentially increasing the life expectancy of the average American 15-year-old today by 0.8 to 1.6 years.

Editors’ Recommendations

May 29, 2018

Fact of the Week: If not for the 2002 EU e-Privacy Directive, Venture Capital Investments into EU-Based Online Services Firms Could Have Been 57 Percent Greater, Cumulatively, by 2013

June 4, 2018

Fact of the Week: In Mexican Manufacturing Firms, Increasing the Share of Workers Using Computers by 10 Percent Raises Productivity by 17 Percent

June 11, 2018

Fact of the Week: If Drug Price Controls Were Lifted Throughout the OECD, the Number of new Treatments Available Would Increase 9 to 12 Percent by 2030

Editors’ Recommendations

Fact of the Week: If not for the 2002 EU e-Privacy Directive, Venture Capital Investments into EU-Based Online Services Firms Could Have Been 57 Percent Greater, Cumulatively, by 2013

Fact of the Week: In Mexican Manufacturing Firms, Increasing the Share of Workers Using Computers by 10 Percent Raises Productivity by 17 Percent

Fact of the Week: Approximately 70 Percent of the Patents Owned by Failed Tech Start-Ups are Eventually Purchased by Other Companies